Gaucher Disease is an autosomal recessive disease and the most prevalent
Lysosomal Storage Disorder (LSD), with an incidence of about 1 in 20,000
live births. Despite the fact that Gaucher Disease consists of a phenotype,
with varying degrees of severity, it has been sub-divided in three subtypes
according to the presence or absence of neurological involvement. It is
also the most common genetic disease affecting Ashkenazi Jewish people
(Eastern, Central and Northern European ancestry), with a carrier frequency
of 1 in 10 (Dr. John Barranger and Dr. Ed Ginns 1989). This panethnic
disease involves many organ systems, such as liver, spleen, lungs, brain,
metabolism and bone marrow.
Gaucher Disease results from a specific enzyme deficiency in the body,
caused by a genetic mutation received from both parents. The disease course
is quite variable, ranging from no outward symptoms to severe disability and
death. Testing, through a simple blood test, is available to identify
potential parents who are carriers of the gene and to accurately diagnose
those people who have the disease. Fortunately, effective treatments are
available for some variants of the Disease.
Learn more about Gaucher Disease by clicking on a link below:
Prevalence
Symptoms
Testing
Treatments
Clinical Course
Research |

Dr. Philippe Gaucher first described, in 1882, the symptoms now known as Gaucher Disease. |